Orchestra BioMed develops medical device therapies for high blood pressure and artery disease, working with large device makers such as Medtronic. It last closed at $6.97 on Nov 17, down 2.11% on the day. The average 12-month price target from 3 analysts is $11.67 (+67.4% from the last close), with a high of $12.00 and a low of $11.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell). In the past 30 days there were 1 dark pool print totaling $144K, the largest $144K.
Each firm's latest rating on OBIO in the past 90 days
Average 12-month target
$11.67
▲ 67.4% upside
Based on 3 analysts who set a price target on OBIO in the past 90 days. The average target is $11.67, with a high of $12.00 and a low of $11.00, compared with the last close of $6.97.
Low $11.00Avg $11.67High $12.00
Blue marker: last close $6.97
Highest target$12.00
Average target$11.67
Lowest target$11.00
Latest rating changes
HC Wainwright & Co.Maintained
Nov 13Buy$12
BTIGTarget raised
Nov 13Buy$10 → $12
B. Riley SecuritiesMaintained
Sep 15Buy$11
BTIGUpgrade
Sep 10Buy$10
Piper SandlerReiterated
Aug 11Buy$10
Date
Firm
Action
Rating
Price target
Nov 13
HC Wainwright & Co.
Maintained
Buy
$12
Nov 13
BTIG
Target raised
Buy
$10 → $12
Sep 15
B. Riley Securities
Maintained
Buy
$11
Sep 10
BTIG
Upgrade
Buy
$10
Aug 11
Piper Sandler
Reiterated
Buy
$10
Loading…
Technical Analysis
OBIO · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought
The stock is 14% above its 20 day and 15% above its 50 day average. It is 33% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 66), near overbought. The nearest support is the Pivot S1 at $6.82, and the nearest resistance the Pivot at $7.09.
Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityHigh, 6.7%/day
Key levels
$7.4552 week high+6.9%
$7.24Pivot R1+3.9%
$7.09Pivot+1.7%
$6.97Last close
$6.82Pivot S1−2.2%
$5.9820 day average−14.2%
$5.9450 day average−14.8%
$5.75Swing low (Sep 24)−17.5%
$5.17100 day average−25.8%
$4.66200 day average−33.1%
$3.4652 week low−50.4%
Indicators
RSI (14)
65.88
Strong, overbought above 70
Neutral
MACD
0.27
Above its signal line
Bullish
Stochastic
86.6
Near the top of its range
Overbought
ADX (14)
18.2
No clear trend
Williams %R
-20.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
215.4
Oversold below −100, overbought above 100
Overbought
Rate of change
+25.4%
Change over 10 sessions
Bullish
ATR (14)
$0.47
Typical daily range, 6.7% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Bounce inside a longer downtrend, nearing overbought
Short trendBullish
Long trendBearish
MomentumStrong
StretchNear overbought
VolatilityNormal, 10.5%/day
Key levels
$7.4552 week high+6.9%
$7.24Pivot R1+3.9%
$7.09Pivot+1.7%
$6.97Last close
$6.82Pivot S1−2.2%
$5.9820 day average−14.2%
$5.9450 day average−14.8%
$5.75Swing low (Sep 24)−17.5%
$5.17100 day average−25.8%
$4.66200 day average−33.1%
$3.4652 week low−50.4%
Indicators
RSI (14)
68.61
Strong, overbought above 70
Neutral
MACD
0.61
Above its signal line
Bullish
Stochastic
82.9
Near the top of its range
Overbought
ADX (14)
35.6
Trending up
Williams %R
-15.5
Oversold below −80, overbought above −20
Overbought
CCI (20)
149.6
Oversold below −100, overbought above 100
Overbought
Rate of change
+13.9%
Change over 10 sessions
Bullish
ATR (14)
$0.73
Typical daily range, 10.5% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for OBIO
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how OBIO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow OBIO usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How OBIO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether OBIO is in one of them and how their past OBIO trades turned out.
Orchestra BioMed is a biomedical company based in New Hope, Pennsylvania, that develops medical device therapies. Its main candidates are AVIM Therapy, a bioelectronic treatment for high blood pressure that can be added to cardiac pacemakers as a software update, and Virtue SAB, a drug and device balloon for treating narrowed arteries. The company works with large medical device makers, including Medtronic, to bring these technologies to patients. Both products are still in clinical study and have not yet been approved by regulators.